Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elagolix in Endometriosis
NCT00797225Phase 2Completed
- Sponsor
- AbbVie Inc.
- Start
- Nov 2008
- Primary completion
- Feb 2010
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of elagolix in endometriosis, sponsored by AbbVie Inc.. Started Nov 2008; status: completed.
02
Drugs
elagolix
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT00797225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00797225.